Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Acorn Bioventures is a venture capital firm based in New York, New York, that invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. The firm's investment process is based on fundamental research, seeking paradigm-changing medical therapies and undiscovered or underappreciated assets, backed by outstanding teams. They offer flexible funding options across multiple financing stages, including seed rounds, IPOs, PIPEs, and open market purchases, enabling long-term support for entrepreneurial biotech ventures.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is Acorn Bioventures' primary investment focus?
- Acorn Bioventures primarily focuses on the Health Tech & Life Sciences sector, with both of its recorded investments falling into this category.
- Can you name some of Acorn Bioventures' portfolio companies?
- Acorn Bioventures' portfolio includes Impulse Dynamics, which develops a minimally invasive implantable device for chronic heart failure.
- What is the typical investment range for Acorn Bioventures?
- Acorn Bioventures typically invests between $80.25M and $120M per round.
- When did Acorn Bioventures make its most recent investment?
- Acorn Bioventures made its most recent investment in July 2023.
- What funding stages does Acorn Bioventures typically participate in?
- Acorn Bioventures has participated in D Round and PIPE funding stages.
- Where is Acorn Bioventures headquartered?
- Acorn Bioventures is headquartered in the United States.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2017 |
|---|